U.S. stock futures were lower this morning, with the Dow futures falling around 250 points on Thursday.

Shares of Highpeak Energy Inc (NASDAQ:HPK) fell sharply in pre-market trading after the company reported worse-than-expected quarterly financial results.

HighPeak Energy reported quarterly losses of 21 cents per share which missed the analyst consensus estimate of losses of 7 cents per share. The company reported quarterly sales of $165.839 million which missed the analyst consensus estimate of $190.563 million.

Highpeak Energy shares dipped 7% to $5.44 in pre-market trading.

Here are some other stocks moving lower in pre-market trading.

• Netskope Inc (NASDAQ:NTSK) tumbled 15.7% to $10.23 in pre-market trading after posting fourth-quarter results.
• Iperionx Ltd (NYSE:IPX) fell 10.2% to $44.54 in pre-market trading.
• Honda Motor Co Ltd (NYSE:HMC) shares dipped 7.7% to $25.43 in pre-market trading.
• KALA BIO Inc (NASDAQ:KALA) fell 6.6% to $0.34 in pre-market trading. Kala Bio shares jumped 24% on Wednesday after the company announced that its first commercial healthcare AI product will be ready to ship in approximately 14 days.
• Astec Industries Inc (NASDAQ:ASTE) fell 6.3% to $52.71 in pre-market trading.
• Freecast Inc (NASDAQ:CAST) declined 6.3% to $7.50 in pre-market trading after falling 12% on Wednesday.
• Descartes Systems Group Inc (NASDAQ:DSGX) fell 5.9% to $65.00 in pre-market trading following quarterly results.
• UiPath Inc (NYSE:PATH) fell 5.7% to $11.66 in pre-market trading after the company reported fourth-quarter results and announced a new $500m stock repurchase authorization.
• Iovance Biotherapeutics Inc (NASDAQ:IOVA) declined 4.3% to $4.63 in pre-market trading after falling around 7% on Wednesday.
• Pinterest Inc (NYSE:PINS) slipped 4% to $18.60 in pre-market trading.

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.